Due to ongoing labour disputes, Canada Post services will be suspended, which may impact some of our FIT and Integrative Laboratory Services (ILS) clients. Read more
Back to Test Catalogue

Risperidone and Metabolite, Serum/Plasma

Test ID: RISPER

Test

Aliases/Synonyms

9-hydroxyrisperidone; paliperidone

Method

LC/MS

Report Includes

Risperidone; 9-Hydroxyrisperidone; Risperidone + 9-Hydroxyrisperidone

Specimens

Avoid gel separator tubes; Serum; Plasma (Heparin)

Test Location

Centre for Addiction and Mental Health, 100 Stokes Street, Toronto, ON M6J 1H4

Test Version

30-Sep-2019

Specimen

Specimens

Avoid gel separator tubes; Serum; Plasma (Heparin)

Sample Volume

2 mL

Specimen Comment

Avoid gel separator tubes.

Collection & Handling

Collection Instructions

Collect trough specimen just prior to next dose or post-dose at a time ≥75% of the dosing interval.

Handling Information

Store and send frozen.

Test Version

30-Sep-2019

Performance / Interpretation

Method

LC/MS

Turnaround Time

10 days

Results

Name Units Reference Range Conversion Factor
Risperidone nmol/L
  • 19.0 - 49.0
ng/mL x 2.44
9-Hydroxyrisperidone nmol/L
  • 19.0 - 211.0
ng/mL x 2.34
9-Hydroxyrisperidone (also known as Paliperidone) is an active metabolite of Risperidone. Please note that the therapeutic range for Paliperidone/9-Hydroxyrisperidone varies by whether patient is administered Paliperidone or Risperidone. The therapeutic range for patients administered Risperidone is displayed above.
Combined (Risperidone + 9-hydroxyrisperidone) nmol/L
  • Therapeutic 19.0 - 260.0
  • Therapeutic ranges are valid for trough specimen collected just prior to next scheduled dose or post-dose at time ≥75% of the dosing interval

Test Location

Centre for Addiction and Mental Health, 100 Stokes Street, Toronto, ON M6J 1H4

Test Version

30-Sep-2019

Interface / Setup

Test Version

30-Sep-2019